{
    "2019-07-10": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Glaxo's Two-Drug HIV Pill Dovato on Par with Three-Drug Pill",
                "features": {
                    "keywords": [
                        "HIV",
                        "Dovato",
                        "Two-Drug",
                        "Three-Drug"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "EpiPen Shortage: Mylan (MYL) Stock Falls on Continued Scarce Supply",
                "features": {
                    "keywords": [
                        "EpiPen",
                        "Shortage",
                        "Mylan",
                        "Stock Falls"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "How This Novartis Mashup Could Validate A Biotech Company's Cancer Drug",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Cancer Drug",
                        "Mashup"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "The 10 Biggest Healthcare Stocks",
                "features": {
                    "keywords": [
                        "Healthcare Stocks",
                        "Biggest"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Jazz (JAZZ) Acquires Early-Stage Precision Oncology Asset",
                "features": {
                    "keywords": [
                        "Jazz",
                        "Acquires",
                        "Precision Oncology"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Here's Why Array BioPharma Soared 75.4% in June",
                "features": {
                    "keywords": [
                        "Array BioPharma",
                        "Soared",
                        "June"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biopharma"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Mylan Falls on Report That EpiPen Shortage Is Hurting Patients and Pharmacists",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Falls",
                        "EpiPen",
                        "Shortage"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "The Daily Biotech Pulse: Jazz Buys Tumor Drug Program, Sanofi's BLA For Multiple Myeloma Drug Accepted, Positive Results For ViiV",
                "features": {
                    "keywords": [
                        "Biotech Pulse",
                        "Jazz",
                        "Tumor Drug",
                        "Sanofi",
                        "BLA",
                        "Multiple Myeloma",
                        "ViiV"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "Aerie Completes Enrollment Under Rhopressa Study in Japan",
                "features": {
                    "keywords": [
                        "Aerie",
                        "Rhopressa",
                        "Study",
                        "Japan"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "Roche Reveals New Hemlibra Data, Extends Spark Merger Deadline",
                "features": {
                    "keywords": [
                        "Roche",
                        "Hemlibra",
                        "Spark",
                        "Merger"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-12",
                "original_text": "Bayer-J&J Announce Positive Xarelto Data in Children with VTE",
                "features": {
                    "keywords": [
                        "Bayer",
                        "J&J",
                        "Xarelto",
                        "Children",
                        "VTE"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-13",
                "original_text": "Novo Nordisk Reports Encouraging Data From Hemophilia Studies",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Hemophilia",
                        "Encouraging Data"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}